Noll Thomas, Jelinek Nanni, Schmid Sebastian, Biselli Manfred, Wandrey Christian
Institut für Biotechnologie 2, Forschungszentrum Jülich GmbH, Germany.
Adv Biochem Eng Biotechnol. 2002;74:111-28. doi: 10.1007/3-540-45736-4_6.
The ex vivo expansion of hematopoietic cells is one of the most challenging fields in cell culture. This is a rapidly growing area of tissue engineering with many potential applications in bone marrow transplantation, transfusion medicine or gene therapy. Over the last few years much progress has been made in understanding hematopoietic differentiation, discovery of cytokines, isolation and identification of cellular subtypes and in the development of a variety of bioreactor concepts. All this has led to a number of (preliminary) clinical trials that gave a hint of the benefits that can be obtained from the use of expanded hematopoietic cells in therapy. Moreover, as we understand the complexity and the regulation of hematopoiesis, it becomes obvious that highly sophisticated cultivation techniques and bioreactor concepts are needed: a new challenge for bioprocess engineering in cell culture.
造血细胞的体外扩增是细胞培养中最具挑战性的领域之一。这是组织工程领域中一个快速发展的领域,在骨髓移植、输血医学或基因治疗中有许多潜在应用。在过去几年中,在理解造血分化、细胞因子的发现、细胞亚型的分离和鉴定以及各种生物反应器概念的开发方面取得了很大进展。所有这些都促成了一些(初步)临床试验,这些试验暗示了在治疗中使用扩增的造血细胞所能获得的益处。此外,随着我们对造血复杂性和调节的理解,很明显需要高度复杂的培养技术和生物反应器概念:这对细胞培养中的生物过程工程来说是一个新的挑战。